Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nutriband Inc (NTRB)

Nutriband Inc (NTRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nutriband Inc 121 South Orange Ave. Suite 1500 Orlando FL 32801 USA

www.nutriband.com Employees: 3 P: 407-377-6695

Sector:

Medical

Description:

Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company is engaged in developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. Nutriband Inc. is based in Orlando, United States.

Key Statistics

Overview:

Market Capitalization, $K 52,840
Enterprise Value, $K 48,590
Shares Outstanding, K 12,175
Float, K 5,818
% Float 47.79%
Short Interest, K 191
Short Float 1.57%
Days to Cover 10.32
Short Volume Ratio 0.75
% of Insider Shareholders 52.21%
% of Institutional Shareholders 19.70%

Financials:

Annual Sales, $ 2,140 K
Annual Net Income, $ -10,480 K
Last Quarter Sales, $ 350 K
Last Quarter Net Income, $ -3,870 K
EBIT, $ -9,250 K
EBITDA, $ -5,340 K

Growth:

1-Year Return -41.71%
3-Year Return 15.43%
5-Year Return -78.29%
5-Year Revenue Growth 478.38%
5-Year Earnings Growth -96.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 12/10/25
Next Earnings Date 04/27/26
Earnings Per Share ttm -2.74
EPS Growth vs. Prev Qtr 84.91%
EPS Growth vs. Prev Year -166.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 07/24/19

NTRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 3.06
Price/Earnings to Growth N/A
Return-on-Equity % -133.22%
Return-on-Assets % -114.00%
Profit Margin % -489.72%
Debt/Equity 0.01
Price/Sales 21.67
Price/Cash Flow N/A
Price/Book 7.14
Book Value/Share 0.62
Interest Coverage -523.00
60-Month Beta 1.87
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar